Want to join the conversation?
$CSC repurchased 3.027MM shares of common stock as of Oct. 2, 2015 under the fourth quarter ASR arrangement for an aggregate consideration of $202MM at a weighted average price of $66.75 per share. Under this fourth quarter ASR arrangement, the final settlement is expected to occur during 3Q16.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.